Blunt Roshawn A. 4
4 · Reneo Pharmaceuticals, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Blunt Roshawn A.
Director
Transactions
- Award
Stock Option (right to buy)
2022-08-02+35,000→ 35,000 totalExercise: $2.80Exp: 2032-08-01→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period.